Jürgens B, Schmitz-Dräger B J, Schulz W A
Urologische Klinik, Heinrich-Heine Universität, Düsseldorf, Germany.
Cancer Res. 1996 Dec 15;56(24):5698-703.
Alterations of DNA methylation were investigated in 6 urothelial carcinoma cell lines and 13 tumor tissues. The methylation of L1 LINE sequences was diminished in all cell lines (by 26 +/- 5%; range, 11-49%) and in most tumors (by 21 +/- 5%; range, 0-60%) compared to normal bladder mucosa. Hypermethylation of the calcitonin gene CpG island was restricted to cell lines and was not found in primary tumors, suggesting it had arisen during culture. In single-cell clones of a urothelial carcinoma cell line, both hypomethylation of L1 sequences and hypermethylation of the calcitonin gene persisted, indicating that they coexist within one cell. DNA methyltransferase expression did not correlate with the methylation status of the cell lines, but rather with histone H3 expression. Accordingly, it was down-regulated in quiescent cells. Aberrant expression of DNA methyltransferase is therefore not likely the cause for altered methylation patterns in urothelial carcinoma. L1 LINE hypomethylation seems to prevail in urothelial carcinoma and in this tumor might be useful for diagnostic or prognostic purposes.
在6种膀胱癌细胞系和13个肿瘤组织中研究了DNA甲基化的改变。与正常膀胱黏膜相比,所有细胞系中L1 LINE序列的甲基化均减少(减少26±5%;范围为11 - 49%),大多数肿瘤中也减少(减少21±5%;范围为0 - 60%)。降钙素基因CpG岛的高甲基化仅限于细胞系,在原发性肿瘤中未发现,提示其在培养过程中出现。在一种膀胱癌细胞系的单细胞克隆中,L1序列的低甲基化和降钙素基因的高甲基化均持续存在,表明它们在一个细胞内共存。DNA甲基转移酶的表达与细胞系的甲基化状态无关,而与组蛋白H3的表达相关。因此,它在静止细胞中下调。所以,DNA甲基转移酶的异常表达不太可能是膀胱癌细胞中甲基化模式改变的原因。L1 LINE低甲基化似乎在膀胱癌中普遍存在,在这种肿瘤中可能对诊断或预后有帮助。